Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)-Reference-Cited by-同舟云学术

Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)

Published:2023-11-28 Issue:1 Volume:119 Page:24-38
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Usuki Kensuke^ORCID,Ohtake Shigeki,Honda Sumihisa,Matsuda Mitsuhiro,Wakita Atsushi,Nawa Yuichiro,Takase Ken,Maeda Akio,Sezaki Nobuo,Yokoyama Hisayuki,Takada Satoru,Hirano Daiki,Tomikawa Tatsuki,Sumi Masahiko,Yano Shingo,Handa Hiroshi,Ota Shuichi,Fujita Hiroyuki,Fujimaki Katsumichi,Mugitani Atsuko,Kojima Kensuke,Kajiguchi Tomohiro,Fujimoto Ko,Asou Norio,Usui Noriko,Ishikawa Yuichi,Katsumi Akira,Matsumura Itaru,Kiyoi Hitoshi,Miyazaki Yasushi

Funder

Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

https://link.springer.com/content/pdf/10.1007/s12185-023-03677-w.pdf

Reference44 articles.

1. NCI Cancer Stats. Acute myeloid leukemia—cancer stat facts. @NCICancerStats; 2023.

2. Miranda-Filho A, Piñeros M, Ferlay J, Soerjomataram I, Monnereau A, Bray F. Epidemiological patterns of leukaemia in 184 countries: a population-based study. Lancet Haematol. 2018;5:e14–24.

3. Chihara D, Ito H, Matsuda T, Shibata A, Katsumi A, Nakamura S, et al. Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol. 2014;164:536–45.

4. Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Rev. 2019;36:70–87.

5. Maynadié M, Girodon F, Manivet-Janoray I, Mounier M, Mugneret F, Bailly F, et al. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d’Or (Burgundy, France). Haematologica. 2011;96:55–61.